Advisornet Financial’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Advisornet Financial's CLB Position: Q2 2026 in Review
Advisornet Financial increased its Core Laboratories (CLB) stake by 65% in Q2 2026, buying an estimated $4.34K and bringing the position to 770 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1622.
Advisornet Financial first reported a position in CLB in Q2 2018 and has held it in 25 quarters since. The position peaked at $19K in Q2 2021. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Advisornet Financial held 770 shares of Core Laboratories worth $8.97K as of Q2 2026.
- Advisornet Financial bought 304 Core Laboratories shares in Q2 2026, an estimated $4.34K.
- Core Laboratories made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1622 holding.
- Advisornet Financial first reported a position in Core Laboratories in Q2 2018 and has held it in 25 quarters since.
- Advisornet Financial's Core Laboratories position peaked at $19K in Q2 2021.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.